Want to see HK:1612 full AI Analyst Report?
Vincent Medical Holdings Limited (1612) Ratios
Vincent Medical Holdings Limited Ratios
HK:1612's free cash flow for Q2 2026 was $-94.21M. For the 2026 fiscal year, HK:1612's free cash flow was decreased by $-28.71M and operating cash flow was $-65.51M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.96 | 2.16 | 2.42 | 2.54 | 2.75 |
| Quick Ratio | 1.52 | 1.56 | 1.69 | 1.73 | 1.62 |
| Cash Ratio | 0.70 | 0.64 | 0.74 | 0.74 | 0.74 |
| Solvency Ratio | 0.28 | 0.27 | 0.39 | 0.10 | 0.41 |
| Operating Cash Flow Ratio | 0.47 | 0.27 | 0.53 | 0.35 | 0.51 |
| Short-Term Operating Cash Flow Coverage | 6.39 | 2.79 | 5.94 | 1.98 | 2.16 |
| Net Current Asset Value | $ 200.49M | $ 251.33M | $ 329.13M | $ 321.17M | $ 395.03M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.15 | 0.11 | 0.05 | 0.08 | 0.07 |
| Debt-to-Equity Ratio | 0.27 | 0.17 | 0.07 | 0.12 | 0.11 |
| Debt-to-Capital Ratio | 0.21 | 0.15 | 0.06 | 0.11 | 0.10 |
| Long-Term Debt-to-Capital Ratio | 0.15 | 0.09 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.76 | 1.59 | 1.45 | 1.46 | 1.41 |
| Debt Service Coverage Ratio | 5.49 | 3.36 | 4.21 | 0.65 | 1.88 |
| Interest Coverage Ratio | 144.27 | 58.49 | 39.11 | -3.86 | 30.68 |
| Debt to Market Cap | 0.27 | 0.31 | 0.08 | 0.09 | 0.08 |
| Interest Debt Per Share | 0.28 | 0.16 | 0.06 | 0.10 | 0.10 |
| Net Debt to EBITDA | -0.43 | -0.74 | -1.33 | -3.30 | -0.96 |
| Profitability Margins | |||||
| Gross Profit Margin | 35.10% | 32.46% | 33.48% | 23.49% | 31.35% |
| EBIT Margin | 14.37% | 9.72% | 9.16% | -1.75% | 9.58% |
| EBITDA Margin | 18.31% | 12.49% | 14.55% | 4.76% | 14.73% |
| Operating Profit Margin | 13.90% | 9.95% | 9.16% | -1.75% | 9.58% |
| Pretax Profit Margin | 13.90% | 9.74% | 9.32% | -2.47% | 8.51% |
| Net Profit Margin | 11.19% | 8.64% | 7.98% | -2.76% | 7.80% |
| Continuous Operations Profit Margin | 11.62% | 8.85% | 8.11% | -2.92% | 7.72% |
| Net Income Per EBT | 80.51% | 88.70% | 85.59% | 112.13% | 91.71% |
| EBT Per EBIT | 99.96% | 97.88% | 101.73% | 141.05% | 88.85% |
| Return on Assets (ROA) | 8.91% | 7.52% | 7.28% | -2.39% | 7.17% |
| Return on Equity (ROE) | 15.70% | 11.96% | 10.57% | -3.49% | 10.14% |
| Return on Capital Employed (ROCE) | 15.92% | 12.30% | 11.96% | -2.16% | 12.14% |
| Return on Invested Capital (ROIC) | 12.69% | 10.54% | 9.77% | -1.95% | 10.07% |
| Return on Tangible Assets | 8.98% | 7.58% | 7.33% | -2.42% | 7.28% |
| Earnings Yield | 19.50% | 26.88% | 23.04% | -4.09% | 9.28% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.04 | 3.99 | 3.84 | 3.58 | 4.23 |
| Payables Turnover | 9.98 | 13.00 | 7.98 | 11.33 | 8.18 |
| Inventory Turnover | 3.91 | 3.32 | 2.75 | 2.77 | 2.02 |
| Fixed Asset Turnover | 2.42 | 2.96 | 4.82 | 5.15 | 5.74 |
| Asset Turnover | 0.80 | 0.87 | 0.91 | 0.87 | 0.92 |
| Working Capital Turnover Ratio | 2.84 | 2.46 | 2.15 | 1.70 | 1.94 |
| Cash Conversion Cycle | 146.92 | 173.29 | 182.29 | 201.67 | 222.33 |
| Days of Sales Outstanding | 90.26 | 91.57 | 95.18 | 101.94 | 86.24 |
| Days of Inventory Outstanding | 93.25 | 109.79 | 132.87 | 131.95 | 180.71 |
| Days of Payables Outstanding | 36.59 | 28.07 | 45.75 | 32.22 | 44.62 |
| Operating Cycle | 183.51 | 201.36 | 228.04 | 233.89 | 266.95 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.26 | 0.11 | 0.19 | 0.12 | 0.18 |
| Free Cash Flow Per Share | 0.08 | -0.04 | 0.09 | 0.09 | 0.14 |
| Dividend Paid and CapEx Coverage Ratio | 1.20 | 0.61 | 1.74 | 1.49 | 1.08 |
| Capital Expenditure Coverage Ratio | 1.48 | 0.73 | 1.96 | 4.10 | 4.79 |
| Operating Cash Flow Coverage Ratio | 0.95 | 0.74 | 3.34 | 1.26 | 1.90 |
| Operating Cash Flow to Sales Ratio | 0.18 | 0.09 | 0.17 | 0.12 | 0.15 |
| Free Cash Flow Yield | 10.21% | -10.31% | 24.65% | 13.57% | 14.44% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 5.19 | 3.72 | 4.34 | -24.42 | 10.78 |
| Price-to-Sales (P/S) Ratio | 0.57 | 0.32 | 0.35 | 0.68 | 0.84 |
| Price-to-Book (P/B) Ratio | 0.81 | 0.44 | 0.46 | 0.85 | 1.09 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 9.80 | -9.70 | 4.06 | 7.37 | 6.93 |
| Price-to-Operating Cash Flow Ratio | 3.18 | 3.50 | 1.99 | 5.57 | 5.48 |
| Price-to-Earnings Growth (PEG) Ratio | 0.11 | 0.15 | -0.01 | 0.19 | -0.15 |
| Enterprise Value Multiple | 2.71 | 1.84 | 1.06 | 10.88 | 4.75 |
| Enterprise Value | 461.94M | 183.54M | 110.18M | 325.98M | 544.12M |
| EV to EBITDA | 2.71 | 1.84 | 1.06 | 10.88 | 4.75 |
| EV to Sales | 0.50 | 0.23 | 0.15 | 0.52 | 0.70 |
| EV to Free Cash Flow | 8.45 | -6.92 | 1.80 | 5.65 | 5.76 |
| EV to Operating Cash Flow | 2.74 | 2.50 | 0.88 | 4.27 | 4.56 |
| Tangible Book Value Per Share | 1.03 | 0.89 | 0.83 | 0.75 | 0.90 |
| Shareholders’ Equity Per Share | 1.03 | 0.90 | 0.84 | 0.76 | 0.91 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.16 | 0.09 | 0.13 | -0.19 | 0.09 |
| Revenue Per Share | 1.45 | 1.25 | 1.11 | 0.96 | 1.19 |
| Net Income Per Share | 0.16 | 0.11 | 0.09 | -0.03 | 0.09 |
| Tax Burden | 0.81 | 0.89 | 0.86 | 1.12 | 0.92 |
| Interest Burden | 0.97 | 1.00 | 1.02 | 1.41 | 0.89 |
| Research & Development to Revenue | 0.05 | 0.04 | 0.05 | 0.06 | 0.05 |
| SG&A to Revenue | 0.16 | 0.19 | 0.14 | 0.16 | 0.11 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.61 | 0.94 | 2.18 | -4.38 | 1.97 |
Currency in HKD